A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Four subgroups based on tau levels in Alzheimer's disease observed in two independent cohorts
Tekijät: Duits Flora H, Wesenhagen Kirsten EJ, Ekblad Laura, Wolters Emma, Willemse Eline AJ, Scheltens Philip, van der Flier Wiesje M, Teunissen Charlotte E, Visser Ppieter Jelle, Tijms Betty M
Kustantaja: BMC
Julkaisuvuosi: 2021
Lehti: Alzheimer's Research and Therapy
Tietokannassa oleva lehden nimi: ALZHEIMERS RESEARCH & THERAPY
Lehden akronyymi: ALZHEIMERS RES THER
Artikkelin numero: ARTN 2
Vuosikerta: 13
Numero: 1
Sivujen määrä: 25
eISSN: 1758-9193
DOI: https://doi.org/10.1186/s13195-020-00713-3
Rinnakkaistallenteen osoite: https://research.utu.fi/converis/portal/detail/Publication/53303602
BackgroundAs Alzheimer's disease (AD) pathology presents decades before dementia manifests, unbiased biomarker cut-points may more closely reflect presence of pathology than clinically defined cut-points. Currently, unbiased cerebrospinal fluid (CSF) tau cut-points are lacking.MethodsWe investigated CSF t-tau and p-tau cut-points across the clinical spectrum using Gaussian mixture modelling, in two independent cohorts (Amsterdam Dementia Cohort and ADNI).ResultsIndividuals with normal cognition (NC) (total n =1111), mild cognitive impairment (MCI) (total n =1213) and Alzheimer's disease dementia (AD) (total n =1524) were included. In both cohorts, four CSF t- and p-tau distributions and three corresponding cut-points were identified. Increasingly high tau subgroups were characterized by steeper MMSE decline and higher progression risk to AD (cohort/platform-dependent HR, t-tau 1.9-21.3; p-tau 2.2-9.5).LimitationsThe number of subjects in some subgroups and subanalyses was small, especially in the highest tau subgroup and in tau PET analyses.ConclusionsIn two independent cohorts, t-tau and p-tau levels showed four subgroups. Increasingly high tau subgroups were associated with faster clinical decline, suggesting our approach may aid in more precise prognoses.
Avainsanat:
Alzheimer's disease, CSF tau, Gaussian mixture modelling
Ladattava julkaisu This is an electronic reprint of the original article. |  |
